Compare TransMedics Group Inc (TMDX) vs Vanguard Short Term Corporate Bond ETF (VCSH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TransMedics Group Inc vs Vanguard Short Term Corporate Bond ETF — how do they compare? TransMedics Group Inc trades at $74.3 (market cap $2.54B), while Vanguard Short Term Corporate Bond ETF trades at $78.58. Which is the better fit depends on your goals.
| TMDX | VCSH | |
|---|---|---|
Market Cap | $2.54B | — |
Sector | Technology | Fixed Income |
52-Week High | $150.42 | $80.20 |
52-Week Low | $61.99 | $78.45 |
Enterprise Value | $2.94B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →About Vanguard Short Term Corporate Bond ETF
VCSH tracks the Bloomberg U.S. 1-5 Year Corporate Bond Index, focusing on high-quality, investment-grade debt with short maturities. It is designed to offer higher income than Treasury bills with significantly lower interest rate sensitivity than intermediate or long-term bond funds.
Read more on VCSH →
